Pomej, K., Frick, A., Scheiner, B., Balcar, L., Pajancic, L., Klotz, A., Kreuter, A., Lampichler, K., Regnat, K., Zinober, K., Trauner, M., Tamandl, D., Gasche, C., Pinter, M. (2025). Study protocol: Fecal Microbiota Transplant combined with Atezolizumab/Bevacizumab in Patients with Hepatocellular Carcinoma who failed to achieve or maintain objective response to Atezolizumab/Bevacizumab – the FAB-HCC pilot study. PLoS ONE. https://doi.org/10.1371/journal.pone.0321189